Keith Lipman

Keith Lipman's work experience includes being the Group Executive Director & Board Member at 30 TECHNOLOGY since January 2019. Keith is responsible for developing and defining new models of care for medical conditions. Previously, Keith worked as an Investor since January 2013. In 2014, they founded 1216 Advisory Services, providing evidence-based advice and data analysis for corporates. Additionally, Keith served as a Director for Edixomed Limited, ONCOBIOPHARM LIMITED, and MEDANNEX LIMITED in 2014. These companies specialized in biopharmaceutical and biotechnology advancements. Prior to that, Keith was a founding partner at Random Walk Partners LLP from April 2003 to October 2012. Before that, they held the position of Executive Director at UBS Investment Bank, where they built a group focused on electronic trading and structured products from September 1995 to April 2003.

Keith Lipman attended the University of Cambridge from 1989 to 1992, where they received their BA and MA (Cantab) degrees in Natural Sciences with a focus on physics. Keith continued their education at the same university from 1992 to 1995 and obtained a PhD in Astrophysics.